Myxomaviral anti-inflammatory serpin reduces myeloid-derived suppressor cells and human pancreatic cancer cell growth in mice

Journal of Cancer Science and Therapy

Volumn 5, Issue 8, 2013, Pages 291-299

  Zheng, Donghang ^a   Chen, Hao ^a   Bartee, Mee Y ^a   Williams, Jennifer ^a   Davids, Jennifer A ^a   Lomas, David A ^c   McFadden, Grant ^b   Lucas, Alexandra R ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Myeloid derived suppressor cell; Pancreatic cancer; Serp 1; Serpin; Tumor associated macrophage

Indexed keywords

M T7; MONOCLONAL ANTIBODY KI 67; NEUROSERPIN; SERINE PROTEINASE INHIBITOR; SERPIN 1; UNCLASSIFIED DRUG; UROKINASE; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER TRANSPLANTATION; CELL ACTIVITY; CELL ASSAY; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; MYXOMA VIRUS; NONHUMAN; PANCREAS CANCER; SPLEEN CELL; SUPPRESSOR CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR XENOGRAFT;

EID: 84884540111     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000219     Document Type: Article

References (37)

1. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140: 883-899.
2. Asgharzadeh S, Salo JA, Ji L, Oberthuer A, Fischer M, et al. (2012) Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. J Clin Oncol 30: 3525-3532.
3. Medrek C, Pontén F, Jirström K, Leandersson K (2012) The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer 12: 306.
4. Qing W, Fang WY, Ye L, Shen LY, Zhang XF, et al. (2012) Density of tumorassociated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma. Thyroid 22: 905-910.
5. Ostrand-Rosenberg S, Sinha P (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 182: 4499-4506.
6. Dass K, Ahmad A, Azmi AS, Sarkar SH, Sarkar FH (2008) Evolving role of uPA/uPAR system in human cancers. Cancer Treat Rev 34: 122-136.
7. Upton C, Macen JL, Wishart DS, McFadden G (1990) Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virology 179: 618-631.
8. Lucas A, Liu L, Dai E, Bot I, Viswanathan K, et al. (2009) The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics. Adv Exp Med Biol 666: 132-156.
9. Viswanathan K, Richardson J, Togonu-Bickersteth B, Dai E, Liu L, et al. (2009) Myxoma viral serpin, Serp-1, inhibits human monocyte adhesion through regulation of actin-binding protein filamin B. J Leukoc Biol 85: 418-426.
10. Dai E, Guan H, Liu L, Little S, McFadden G, et al. (2003) Serp-1, a viral antiinflammatory serpin, regulates cellular serine proteinase and serpin responses to vascular injury. J Biol Chem 278: 18563-18572.
11. Lucas A, Dai E, Liu L, Guan H, Nash P, et al. (2000) Transplant vasculopathy: viral anti-inflammatory serpin regulation of atherogenesis. J Heart Lung Transplant 19: 1029-1038.
12. Miller LW, Dai E, Nash P, Liu L, Icton C, et al. (2000) Inhibition of transplant vasculopathy in a rat aortic allograft model after infusion of anti-inflammatory viral serpin. Circulation 101: 1598-1605.
13. Richardson M, Liu L, Dunphy L, Wong D, Sun Y, et al. (2007) Viral serpin, Serp-1, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model. Cardiovasc Pathol 16: 191-202.
14. Munuswamy-Ramanujam G, Dai E, Liu L, Shnabel M, Sun YM, et al. (2010) Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets. Thromb Haemost 103: 545-555.
15. Tardif JC, L'Allier PL, Grégoire J, Ibrahim R, McFadden G, et al. (2010) A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Circ Cardiovasc Interv 3: 543-548.
16. Liu L, Lalani A, Dai E, Seet B, Macauley C, et al. (2000) The viral antiinflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury. J Clin Invest 105: 1613-1621.
17. Dai E, Liu LY, Wang H, McIvor D, Sun YM, et al. (2010) Inhibition of chemokineglycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection. PLoS One 5: e10510.
18. Bédard EL, Kim P, Jiang J, Parry N, Liu L, et al. (2003) Chemokine-binding viral protein M-T7 prevents chronic rejection in rat renal allografts. Transplantation 76: 249-252.
19. Bartee MY, Dai E, Liu L, Munuswamy-Ramanujam G, Macaulay C, et al. (2009) 10 M-T7: measuring chemokine-modulating activity. Methods Enzymol 460: 209-228.
20. Ostrand-Rosenberg S (2010) Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Cancer Immunol Immunother 59: 1593-1600.
21. Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, et al. (2009) Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicincyclophosphamide chemotherapy. Cancer Immunol Immunother 58: 49-59.
22. Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW (2011) Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother 60: 1419-1430.
23. Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141: 39-51.
24. James ND, Sydes MR, Mason MD, Clarke NW, Anderson J, et al. (2012) Celecoxib plus hormone therapy versus hormone therapy alone for hormonesensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial. Lancet Oncol 13: 549-58.
25. Jin CH, Wang AH, Chen JM, Li RX, Liu XM, et al. (2011) Observation of curative efficacy and prognosis following combination chemotherapy with celecoxib in the treatment of advanced colorectal cancer. J Int Med Res 39: 2129-2140.
26. Sabichi AL, Lee JJ, Grossman HB, Liu S, Richmond E, et al. (2011) A randomized controlled trial of celecoxib to prevent recurrence of nonmuscleinvasive bladder cancer. Cancer Prev Res (Phila) 4: 1580-1589.
27. Wennier ST, Liu J, Li S, Rahman MM, Mona M, et al. (2012) Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer. Mol Ther 20: 759-768.
28. Tan X, Egami H, Nozawa F, Abe M, Baba H (2006) Analysis of the invasionmetastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells. Int J Oncol 28: 369-374.
29. Gorantla B, Asuthkar S, Rao JS, Patel J, Gondi CS (2011) Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells. Mol Cancer Res 9: 377-389.
30. Xue A, Xue M, Jackson C, Smith RC (2009) Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. Int J Biochem Cell Biol 41: 1731-1738.
31. Ulisse S, Baldini E, Sorrenti S, D'Armiento M (2009) The urokinase plasminogen activator system: a target for anti-cancer therapy. Curr Cancer Drug Targets 9: 32-71.
32. Blasi F, Sidenius N (2010) The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling. FEBS Lett 584: 1923-1930.
33. Smith HW, Marshall CJ (2010) Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol 11: 23-36.
34. Evans A, Costello E (2012) The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion. Front Physiol 3: 270.
35. Ostrand-Rosenberg S, Sinha P, Beury DW, Clements VK (2012) Crosstalk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Semin Cancer Biol 22: 275-281.
36. Ilkovitch D, Lopez DM (2009) Urokinase-mediated recruitment of myeloidderived suppressor cells and their suppressive mechanisms are blocked by MUC1/sec. Blood 113: 4729-4739.
37. Ilkovitch D, Carrio R, Lopez DM (2012) uPA and uPA-receptor are involved in cancer-associated myeloid-derived suppressor cell accumulation. Anticancer Res 32: 4263-4270.